<DOC>
	<DOCNO>NCT00426413</DOCNO>
	<brief_summary>Over 50 % obese African-Americans ( AA ) present newly diagnose , severe hyperglycemia and/or unprovoked diabetic ketoacidosis ( DKA ) display clinical , metabolic , immunogenetic feature type 2 diabetes . Prior study indicate patient ) markedly decrease insulin secretion impair insulin action presentation , b ) absent low prevalence beta-cell autoantibody c ) able discontinue aggressive insulin therapy ~70 % case within 3 month follow-up . These patient refer ketosis-prone type 2 diabetes ( KPDM ) . Most patient KPDM , however , experience hyperglycemic relapse within year insulin discontinuation . Consequently , patient `` KPDM '' ideal model follow throughout clinical course . The specific aim proposal 1 ) identify clinical , metabolic , immunogenetic marker alone , combination , predictive short- long-term near-normoglycemic remission 2 ) determine whether pioglitazone sitagliptin therapy delay insulin-deficient relapse insulin discontinue . The Principal Investigator hypothesize measure beta-cell function presentation , alone combination measure insulin sensitivity , correlate ability patient achieve remain near-normoglycemic remission . She also hypothesize intervention compare placebo preserve beta-cell function , improve insulin sensitivity , prevent insulin-deficient relapse . This prospective , cohort study RCT arm would better characterize natural history KPDM , facilitate direction long-term therapy , likely decrease recurrence DKA associate increased mortality morbidity .</brief_summary>
	<brief_title>Ketosis Prone Diabetes African-Americans</brief_title>
	<detailed_description>More half obese African-Americans ( AA ) newly diagnose diabetes present diabetic ketoacidosis ( DKA ) display clinical , metabolic , immunogenetic feature type 2 diabetes follow-up . Prior study group investigator indicate , presentation , patient ) markedly decrease insulin secretion impair insulin action , b ) low prevalence positive B-cell autoantibody , c ) respond aggressive diabetic management significant improvement B-cell function insulin sensitivity sufficient allow discontinuation insulin therapy . Upon discontinuation insulin , period near-normoglycemia remission ( defined ability discontinue insulin injection ≥ one week remain good metabolic control - fasting blood glucose ≤ 120 mg/dl A1c ≤ 7 % ) may last month several year . These patient refer atypical diabetes , Flatbush diabetes , ketosis-prone type 2 diabetes ( KPDM ) . Patients `` KPDM '' therefore ideal model follow throughout clinical course order correlate response treatment mechanism ( ) markers short- long-term remission determine optimal therapeutic approach order prevent future glycemic decompensation .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Ketosis</mesh_term>
	<mesh_term>Diabetic Ketoacidosis</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>36 Obese AA subject DKA severe hyperglycemia 8 obese nondiabetic subject , age 1965 . All study perform GCRC Grady Memorial Hospital . Subjects BMI ≥ 28 kg/m2 include . Diagnostic criterion DKA include : plasma glucose &gt; 250 mg/dl , venous pH &lt; 7.30 , serum bicarbonate &lt; 18 mEq/l , high serum ketone . Obese hyperglycemic patient : blood glucose admission &gt; 400 mg/dl , serum bicarbonate &gt; 18 mEq/l , negative ketone . Patients significant medical surgical illness , include limited myocardial ischemia , congestive heart failure , chronic renal insufficiency , liver failure , infectious process ; Patients recognize endocrine disorder , hypercortisolism , acromegaly , hyperthyroidism ; Bleeding disorder , abnormality coagulation study ; Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>ketosis-prone diabetes</keyword>
	<keyword>diabetic ketoacidosis</keyword>
	<keyword>obesity</keyword>
	<keyword>insulin dependence</keyword>
	<keyword>mechanism</keyword>
</DOC>